Regression of extramedullary haemopoiesis and augmentation of fetal haemoglobin concentration during hydroxyurea therapy in β thalassaemia

British Journal of Haematology

Volumn 101, Issue 3, 1998, Pages 416-419

  Saxon, Ben R ^a   Rees, David ^b   Olivieri, Nancy F ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

thalassaemia; Extramedullary haemopoietic regression; Hydroxyurea

Indexed keywords

ARYLBUTYRIC ACID DERIVATIVE; HYDROXYUREA;

ARTICLE; BETA THALASSEMIA; CASE REPORT; DRUG EFFICACY; DRUG INDICATION; HEMATOPOIESIS; HEMOGLOBIN DETERMINATION; HUMAN; MALE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TREATMENT OUTCOME;

ADULT; BETA-THALASSEMIA; ERYTHROPOIESIS; FETAL HEMOGLOBIN; HEMATOPOIESIS, EXTRAMEDULLARY; HUMANS; HYDROXYUREA; MALE;

EID: 0031832011     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00719.x     Document Type: Article

References (20)

1. Anselm, C.W., Tai, K.S., Wong, V., Peh, W.C.G. & Lau, Y.L. (1996) Hypertransfusion for spinal cord compression secondary to extramedullary hematopoiesis. Pediatric Hematology and Oncology, 13, 89-94.
2. Arruda, V.R., Lima, C.S.P., Saad, S.T.O. & Costa, EE (1997) Successful use of hydroxyurea in β-thalassemia major. New England Journal of Medicine, 336, 964.
3. Bachir, D., Drame, M., Lee, K., Portos, J.-L. & Galacteros, F. (1995) Clinical effects of hydroxyurea in thalassemia intermedia patients. In: Sickle Cell Disease and Thalassemia: New Trends in Therapy. Eds: Beuzard, Y., Lubin, B. & Rosa, J. Colloque INSERM, 234, 195.
4. SCharache, S., Barton, F.B., Moore, R.D., Dover, G.J., Barton, F.B., Eckert, S.V., McMahon, R.P. & Bonds, D.R. (1996) Hydroxyurea and sickle cell anemia. Medicine, 75, 300-326.
5. Coliins, A.F., Pearson, H.A., Giardina, P., McDonagh, K.T., Brusilow, S.W., Dover, G.J. (1995) Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial. Blood, 85, 43-19.
6. Cohen, A.R., Martin, M.B. & Schwartz, E. (1995) Hydroxyurea therapy in thalassemia intermedia. In: Sickle Cell Disease and Thalassemia: New Trends in Therapy. Eds: Beuzard, Y., Lubin, B. & Rosa, J. Colloque INSERM, 214, 193-194.
7. Fucharoen, S., Siritanaratkul, N., Winichagoon, P., Chowthaworn, J., Siriboon, W., Muangsup, W., Chaicharoen, S., Poolsup, P., Chindavijak, B., Pootrakul, P., Piankijagum, A. & Rodgers, G.P. (1996) Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in β-thalassemia/hemoglobin E disease. Blood, 87, 887-892.
8. Gonzalez-Redondo, J.M., Stoming, T.A., Lanclos, K.D., Gu, Y.C., Kutlar, A., Kutlar, F., Nakatsuji, T., Deng, B., Han, I.S., McKie, V.C. & Huisman, T.H.J. (1988) Clinical and genetic heterogeneity in black patients with homozygous β-thalassemia from the southeastern United States. Blood, 72. 1007-1014.
9. Hajjar, F.M. & Pearson, H.A. (1994) Pharmacologic treatment of thalassemia intermedia with hydroxyurea. Journal of Pediatrics, 125, 490-492.
10. Huang, S-Z., Ren, Z-R., Chen, M-J., Xu, H-P., Zeng, Y-T., Rodgers, G.P., Zeng, F.-Y. & Schechter, A.N. (1994) Treatment of β-thalassemia with hydroxyurea (HU): effects of HU on globin gene expression. Science in China (Series B), 17, 1350-1359.
11. Hussein, I.R., Temtamy, S.A., El-Beshlawy, A., Fearon, C., Shalaby, Z., Vassilopoulos, G. & Kazazian, H.H., Jr (1993) Molecular characterization of beta-thalassemia in Egyptians. Human Mutation, 2, 48-52.
12. Konstantopoulos, K., Vagiopoulos, G., Kantouni, R., Lymperi, S., Patriarcheas, G., Georgakkopoulos, D. & Fessas, P. (1992) A case report of spinal cord compression by extramedullary haemopoiesis in a thalassaemic patient: a putative role for hydroxyurea? Haematologica, 77, 352-354.
13. Mancuso, P., Zingale, A., Basile, L., Chiaramonte, I. & Tropea, R. (1993) Cauda equina compression syndrome in a patient affected by thalassemia intermedia: complete regression with blood transfusion therapy. Child's Nervous System, 9, 440-441.
14. McDonagh, K.T., Orringer, E.P., Dover, G.J. & Nienhuis, A.W. (1990) Hydroxurea improves erythropoiesis in a patient with homozygous beta thalassemia. Clinical Research, 38, 346A (abstract).
15. Olivieri, N.F., Rees, D.C., Ginder, G.D., Thein, S.L., Brittenham, G.M., Waye, J.S. & Weatherall, D.J. (1997) Treatment of thalassaemia major with phenylbutyrate and hydroxyurea. Lancet, 350, 491-492.
16. Piomelli, S., Danoff, S., Becker, M., Lipera, M. & Travis, S. (1969) Prevention of bone malformations and cardiomegaly in Cooley's anemia by early hypertransfusion regimen. Annals of the New York Academy of Sciences, 165, 427.
17. Rigano, P., Manfré, L., La Galla, R., Renda, D., Renda, M.C., Calabrese, A., Calzolari, R. & Maggio, A. (1997) Clinical and hematologic response to hydroxyurea in a patient with hemoglobin Lepore/β-thalassemia Hemoglobin, 21, 219-26.
18. Wolman, I.J. (1964) Transfusion therapy in Cooley's anemia: growth and health as related to long range hemoglobin levels: a progress report. Annals of the New York Academy of Sciences, 119. 736.
19. Wong, C., Antonarakis, S.E., Goff, S.C., Orkin, S.H., Forget, B.G., Nathan, D.G., Giardina, P.J.V. & Kazazian, H.H., Jr (1989) β-Thalassemia due to two novel nucleotide substitutions in consensus acceptor splice sequences of the β-globin gene. Blood, 73, 914-918.
20. Zeng, Y-T., Huang, S-Z., Ren, Z-R., Lu, Z-H., Zeng, F-Y., Schechter, A.N. & Rodgers, G.P. (1995) Hydroxyurea therapy in β-thalassaemia intermedia: improvement in haematological parameters due to enhanced β-globin synthesis. British Journal of Haematology, 90, 557-563.